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Domain interactions of C-terminal Src Kinase
determined through NMR spectroscopy
with segmental isotope labeling
Dear Editor,
Proteins with large molecular weight exhibit increased number
of NMR signals, and the resulting spectral overlap typically
imposes limitations. Segmental isotope labeling of individual
domains of multidomain protein facilitates spectral interpreta-
tion by reducing the number of signals and thus provides a
solution to spectral overlap (Liu et al., 2009). This is particularly
applicable to multidomain proteins in signaling like kinases.
This NMR study was performed using a 50 kDa protein C--
terminal Src kinase (Csk) with segmental labeling (Figure S1).
The interactions among SH3, SH2 and kinase domains in the
solution were identiﬁed. Consistent with mutational and
structural studies, interdomain interactions were found
between the SH2 and kinase domains. On the basis of
chemical shift perturbation, the major regions that interacted
with the kinase domain included SH3-SH2 and βB-βC linkers,
part of βD, βD-βE linker of SH2 domain and SH2-kinase linker
region. Thus, phosphotyrosyl ligand binding induced major
conformational changes in the SH3-SH2 and βB-βC linkers,
part of βD, and βD-βE linker region, thereby allowing modu-
lating kinase activity through domain interactions.
Whether Csk is dimeric or monomeric in solution remains
controversial (Ogawa et al., 2002; Levinson et al., 2009;
Jamros et al., 2010). The protein sample in the present study
was investigated using size exclusion chromatography
(SEC), small angle X-ray Scattering (SAXS), dynamic light
scattering (DLS) and analytical ultracentrifugation (AUC).
Full-length Csk in SEC, SAXS and DLS shows a dimer form
and a truncated form of the SH2-kinase protein, which is not
dimerized (Figs. S2 and S3) with gel ﬁltration elution, indi-
cating monomer. This result strongly supports the concept
that Csk SH3 domain participates in the dimer interface, as
suggested by the similarity in the crystal structures of the
SH3 dimer (PDB 1CSK) (Ogawa et al., 2002) and SH3 in full-
length Csk. The dimerization constant determined via AUC is
1.0 μmol/L (Fig. S3). Analysis of SAXS, DLS, and AUC
showed that 3BP1 peptide addition produces a monomeric
Csk (Fig. S3), which is presumably formed in vivo in the
presence of the prolyl-rich peptide(s) of Lyp phosphatase, as
mimicked by 3BP1 in the current experiments.
To perform the segmental labeling of Csk, the selected
ligation point is located within the SH2-kinase linker region
(V172–E194) that connects the two domains (Fig. S1).
Fig. S1C illustrates the generation of the tandem SH3-SH2
(hereafter called as SH32) domain activated at its C terminus
as α-thioester and the kinase domain containing a N-terminal
cysteine residue. When combined under physiological con-
ditions, the SH32 and kinase domains chemoselectively
react through the well-established traditional chemical liga-
tion (Dawson et al., 1994) reaction to form an amide linkage
at the ligation junction. Fig. S4A illustrates the puriﬁcation
procedure used in this study, that is, afﬁnity column followed
by ion exchange chromatography. MALDI-TOF was used to
conﬁrm the molecular weight of the ligation product
(Table S1, Fig. S4D and S4E). These results demonstrated
that expressed protein ligation methods could be success-
fully used for segmental labeling of NMR sample in large
systems. Fig. 1 shows the overlay of 1H-15N-HSQC spectra
of the Csk SH32 with and without ligated kinase. The red
spectrum is isolated Csk [15N] SH32, and the blue one is
[15N] SH32 with ligated unlabeled kinase. Figs S6 and S7
demonstrate the overlay of the 1H-15N HSQC spectra of
[15N, 2H] kinase with and without ligated SH32 or SH2,
respectively.
To probe possible minor structural changes among the
Csk domains, we measured the chemical shift changes that
accompany the formation of full-length Csk through ligation
of the kinase domain with the SH32 domain (Fig. 1). Two
distinct types of resonance changes were observed in the
1H-15N HSQC spectrum: (1) chemical shift changes among
the peaks, which are indicative of changes in local environ-
ment, and (2) resonances that underwent signiﬁcant line
broadening, thus suggesting local changes caused by con-
formational exchange (Fig. 2A and 2B). These changes are
localized to several stretches in the SH2 domain (Fig. 2B).
Maximal changes in the chemical shifts were observed for
residue A178 (1H and 15N chemical shifts of 0.41 and 6.38
ppm, respectively) and likely caused by the local effect of
ligation. Other changes in chemical shifts occur in four
regions, namely, K76–K86 (SH3-SH2 linker), V107-Y116
(βB-βC linker), Y129–S137 (βD, βD-βE linker), and V172-
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A178 (SH2-kinase linker) regions, are all spatially close to
the N-lobe of kinase domain (Fig. 2C) in the full-length Csk
crystal structure. The observed shifts indicate that some
structural changes in this region accompany the ligation of
the kinase domain.
The ligation of the kinase domain to the SH32 domains
causes a global reduction of signal intensities because of
the increase in the molecular weight of the ligated SH32-
kinase protein. Consequently, the overall correlation time is
increased. A close inspection shows differential line broad-
ening, which reveals the different dynamic interactions
between SH3 and SH2 with the kinase domain. As shown in
Fig. 2A, the average relative peak intensity of SH2 (30%) is
only half of that of the SH3 (60%) domain (normalized
against the peak intensity for residue I4), suggesting that
conformational changes occur in the SH2 domain in the
solution. This observation is consistent with the crystal
structure containing dual SH2 conformations, which causes
active and inactive kinase status. Additionally, this phe-
nomenon can occur either because of a tight interaction of
the SH2 domain with the kinase domain or from the con-
formational exchange between states.
Superposition of the 1H-15N HSQC spectra of free SH2
and kinase ligated SH2 shows the chemical shift perturba-
tions upon ligation (Fig. S5A). The largest of the observed
chemical shift perturbations occurred at S78, L79, and M80,
and the C-terminal tail of the SH2 domain, with the largest
absolute change involving Y116. From the crystal structure
of kinase, we can hypothesize that this arises from the close



































































































Figure 1. Structure perturbation of Csk identiﬁed by 1H-15N-HSQC spectra. Overlay of 1H-15N-HSQC spectra of the Csk SH32
with and without ligated kinase. Red: Csk [15N] SH32; Blue: [15N] SH32 ligated with unlabeled-kinase. Both of the two samples are
concentrated to 0.1 mmol/L and complexed with 1 mmol/L 3BP1. The peaks indicated by arrows show signiﬁcant chemical shift
perturbations.
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the βBC, βC and two β-strands on kinase domain (Fig. S5B).
These data show that interaction between the SH2 and
kinase domain described above is present even in the
absence of the SH3 domain.
While chemical shift perturbations can be a useful means
of mapping interfacial regions within Csk, they are not
commonly indicative of the degree of conformational plas-
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Figure 2. Structural perturbation observed via segmental labeling methods. (A) Changes on peak intensity of the SH32 domain
with and without ligated kinase domain. The peak intensity of I4 is normalized to 100%. The average relative peak intensity of SH2
(31%) is only half of the SH3 (60%) domain, thereby suggesting a different interaction mode for these two domains. The locations of
the SH3 and SH2 domains are indicated above the plot. (B) The combined chemical shift change of a particular residue upon ligation
with the kinase domain. (C) Chemical shift perturbation mapped onto the crystal structure of Csk (1K9A-A). The red regions are the
regions that undergo a big chemical shift change before and after SH32 ligation with the kinase domain.
Segmental labeling NMR of Csk LETTER









the active and inactive molecules in the SH2-kinase interface
in the full-length Csk. The interactions between the βD-βE
loop of the SH2 domain and β3-βC loop in the N-lobe of
kinase domain are absent in putative inactive molecules
(Ogawa et al., 2002). The comparison of SH2 structures in
active full length, inactive full length, and isolated form also
shows that the βD-βE and βB-βC loop positions are signiﬁ-
cantly changed between the active form, inactive form and
isolated SH2 (Liu and Cowburn, 2016). βD-βE and βB-βC
loops in active form of SH2 from full-length Csk show major
domain interactions, and inactive form SH2 from full-length
Csk shows minor domain interactions.
Ligands for the SH3 and SH2 domains may play signiﬁcant
roles, in controlling the kinase activities. Cbp binding poten-
tially activates ligand localization for Csk kinase activity
(Takeuchi et al., 2000; Wong et al., 2005). Csk and the cyto-
plasmic domain of phosphorylated Cbp form a stable complex
and enhance the afﬁnity of Csk toward Src (Takeuchi et al.,
2000). Csk binding toCbp increases the catalytic activity of the
former, as identiﬁed in vitro and in vivo. This activation is
accompanied by a two- to six- fold decrease in theKm for Src in
the presence of Cbp or Cbp peptide (Takeuchi et al., 2000).
Csk could be regulated by coupling of the SH2 and kinase
domains; this coupling may provide an intramolecular activa-
tion mechanism for Csk (Ogawa et al., 2002).
In addition to the SH3-SH2 linker, three other identiﬁed
regions, namely, βB-βC linker, part ofβDand βD-βE linker, and
the SH2-kinase linker, underwent changes in chemical shift
upon ligationwith kinase domain; these regions are all spatially
close to the kinase domain N-lobe in the crystal structure. One
of the largestobservedchemical shift perturbationsoccurred for
residue Y116 (0.01 and 0.40 for 1H and 15N, respectively). The
Y116A mutant lost its ability to be activated by SH2 domain
ligand almost completely, which suggests that the hydrophobic
pocket formedby thesidechainsofY116,Y133,L138andL149
must be intact for the SH2 domain-mediated activation of Csk
(Mikkola andGahmberg, 2010). Notably, in the presence of the
SH3 domain, the SH2 domain is structurally close to the Csk
kinasedomain, thereby causing further structural interactions in
the βB-βC linker, part of the βD and βD-βE linkers, and SH2-
kinase linker with kinase domain. This result can be explained
by the fact that only the SH3-SH2 linker region still retains a
signiﬁcant interaction with the kinase domain on SH3 trunca-
tion. The ligation of kinase domain to the SH32 domain causes
a global change of signal intensities, which shows that ligation
increases the overall correlation time, as expected. However,
the intensity variations are not uniform across resonances from
both the SH3 and SH2 domains, thus suggesting a different
interactionmode for these two domains and partially conﬁrming
a tight association of the SH2 domain with the kinase domain.
The ligand to Csk SH2 is Cbp. Cbp has been implicated in
various aspects of cancer cell biology (Hrdinka and Horejsi,
2014). Cbp could function as both a positive and negative
regulator of mast cell signaling, depending upon the signal-
ing pathway involved (Draberova et al., 2014). Cbp also
serves as a central inhibitor of c-Src and other Src family
kinases, as a novel tumor suppressor in neuroblastoma
(Agarwal et al., 2016). Previously, we have studied the
interaction of Csk L-SH2 with Cbp peptide using L-SH2
sample with and without binding with Cbp peptide (Liu and
Cowburn, 2016). The perturbed residues upon Cbp binding
indicate that βB-βC, βD and βD-βE loops of L-SH2 undergo
signiﬁcant conformational change. In addition, βA-βA loop
residues at the N-terminal also undergo small-range pertur-
bation upon the binding of phosphopeptide with K86 and I87
in this loop. These results suggest that Cbp binding causes
dramatic conformational changes in the βB-βC, βD and βD-
βE loops, which are all spatially close to the N-lobe of Csk
kinase domain. In the present study, we focused on how the
activation signal is transferred from the peptide-bound SH2
domain to the kinase domain using segmental labeling NMR
methods. Comparison of phosphotyrosyl peptide-bound Src
SH2 domain crystal structure (1SPS) with free Csk SH2 (with
SH3-SH2 linker) crystal structure revealed that the βB- βC
and βD-βE loops of the SH2 domain exhibit the largest
conformational change upon complex formation. In addition
to the Y116, which is the largest perturbation found in NMR,
the Y112 conformation is changed signiﬁcantly with and
without the presence of kinase domain. In the lack of proper
interacting partner, Y112 side chain folds back to SH2
domain. Overall, we suggest that phosphotyrosyl ligand
binding causes conformational changes in the SH3-SH2 and
βB- βC linkers, part of the βD, and βD-βE linker region,
thereby allowing for modulation of kinase activity.
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